Ron Chiarello, Ph.D.


When Molecular Testing is Superior to Antigen Testing for Infectious Diseases

Providing people with the ability to test for viruses in their own homes empowers them to be proactive about their health while helping public health officials, policymakers, and researchers with information that could head off the next pandemic.

Don Via, a Good Neighbor Pharmacy Business Coach at AmerisourceBergen


Three Small Staffing Changes That Can Boost Your Pharmacy's Profits

Although there's no magic formula for finding the appropriate pharmacy staffing levels, there are subtle shifts you can make that will have a big impact on your bottom line.

Gabriella Salerno, PharmD


FDA Approves Voquezna for Helicobacter pylori Infection in Adults

This new treatment option copackages 3 drugs for optimal treatment.

James Thurston, PharmD Candidate


TICOVAC Vaccine to Prevent Tick-Borne Encephalitis

The FDA approved a biologics license application for the tick-borne encephalitis (TBE) vaccine TICOVAC for individuals 1 year or older.

Judy Neville, CPhT


Pharmacy Technicians on the Front Line of Health Care

The need for skilled and knowledgeable pharmacy technicians in our workforce remains steady throughout current times.

Rachel Pearlman, PharmD candidate


The Evolution of Pharmacogenomics

Pharmacogenomics provides an opportunity for pharmacists to enhance their role in patient care.

Teri Metcalf McCambridge, MD


OTC Medications to Treat the Young Athlete

A variety of nonprescription treatments, supplements, and patches can alleviate pain for children and adolescents.

Jeffrey Benedix


Appeals Court Temporarily Upholds Mandate For ACA Preventive Services

Health plans must continue providing free screenings pending court’s further consideration of case.

Innocent Clement, M.D., M.P.H., MBA


How Can Improving Provider-Patient Relationships Help Reverse Chronic Disease?

The existing approach to disease management may be ill-suited to address the dynamic and diverse factors at play when it comes to chronic illness.

Mary Caffrey


Does the Cost of Preventive Drugs Change Health Outcomes?

Researchers shared findings from the ACCESS study presented at the 72nd American College of Cardiology Annual Scientific Sessions.

Gina Mauro


Pembrolizumab Approved in China for Frontline Advanced Esophageal Cancer

The National Medical Products Administration in China has approved pembrolizumab for use in combination with platinum and fluoropyrimidine-based chemotherapy for the frontline treatment of patients.

Pearl Steinzor


Patients with COPD and Sleep Apnea See Improved Lung Function with CPAP Compliance

Patients with good continuous positive airway pressure (CPAP) compliance saw improvements in lung function after 12 months, compared to patients with poor CPAP compliance.

Gianna Melillo


Polycythemia Vera Treatments Potentially Not Being Used to Their Full Advantage

Data suggest a substantial reliance on established therapies for polycythemia vera, despite access to all available treatment options.

Anne Chau


Data, Collaboration Can Help Unlock the Full Potential of Value-Based Care

A unified data ecosystem will provide the foundation for the next generation of patient-care technology.

Brock Ingmire


How to Help Make Health Equity a Reality

CMS and state officials are using payment incentives, data collection and program requirements to start edging the lofty ideals of health equity toward reality.

Jennifer Gershman, PharmD, CPh, PACS


Two-Dose HepB Vaccine Not Associated With Increased Risk of Acute MI

The 2-dose hepatitis B vaccine was not associated with a higher risk of acute myocardial infarction compared with the 3-dose hepatitis B vaccine series.

Kaitlyn Bader


Boxed Warnings Should Not Inhibit Use of All JAK Inhibitors for AD

Brett King, MD, PhD, gave an in-depth overview of how JAK inhibitors earned a boxed warning and what it means for treating patients with atopic dermatitis at RAD 2023.

John Kassis, PharmD


Barhemsys (Amisulpride) for Postoperative Nausea and Vomiting

On February 27, 2020, the FDA approved an intravenous solution of amisulpride (Barhemsys; Acacia Pharma) to treat and prevent postoperative nausea and vomiting.

Rachel Lutz


COVID-19 Variant, Omicron, Connected to Worse Maternal Outcome in Pregnant Women

“Vaccination coverage among pregnant women remains a priority,” the researchers wrote.

Jared Kaltwasser


Myasthenia Gravis Patients Fare Better With COVID-19 When Vaccinated

Unvaccinated patients who were older at MG onset and at SARS-CoV-2 infection had more severe cases.

Diana Issacs, PharmD, BCPS, BCACP, BC-ADM, CDCES


Continuous Glucose Monitoring and Its Part in Diabetes Management

Continuous glucose monitoring has many benefits and can improve disease management in for both diabetes types.

Janet Walker


How to Help Make Health Equity a Reality

CMS and state officials are using payment incentives, data collection and program requirements to start edging the lofty ideals of health equity toward reality.

Joshua Fitch


Nalmefene Nasal Spray for Emergency Opioid Overdose Treatment Gets FDA Approval

The newly FDA-approved prescription product delivers nalmefene to the nasal cavity to reverse the effects of opioid overdose.

Sandra Bond Chapman, PhD


Mind-Body Resilience for Women: A Focus on Depression

Developing innovative solutions for women with depression, accounting for differences in gender and sex, are critically important

Lauren Buchanan


Triple-Combination, Fixed-Dose Acne Gel Shows Promise as Treatment

The once-daily, triple-combination gel led to a marked reduction in moderate to severe acne.

Caitlin McCafferty


USDA provides conditional license for Canine Parvovirus Monoclonal Antibody

The brand-new treatment from Elanco is currently the only approved therapeutic solution proven to treat canine parvovirus.

Sam McAleese, M.D


What's Next in Development of RSV Vaccines for Children?

How much progress have we made in developing therapies to treat this common childhood respiratory disorder?

Chris Ryan


FDA Approves Drug Combo for Young Glioma Patients

A combination of dabrafenib with trametinib was approved by the FDA for treatment of pediatric patients 1 year and older with low-grade glioma & BRAF V600E mutation who require systemic therapy.

© 2023 MJH Life Sciences

All rights reserved.